U.S. Medical Equipment Stock News

In late July 2026, Dynamis Power Solutions and Venture Global LNG announced major orders for Baker Hughes equipment, including 76 NovaLT™16 gas turbines for hypermobile power generation and a comprehensive liquefaction package for Venture Global’s CP2 LNG project in Louisiana. These wins highlight Baker Hughes’ growing exposure to data center power needs and large-scale LNG infrastructure, underscoring the breadth of demand for its turbines, compressors, and related systems across digital...

Aflac recently supported the United Way of the Chattahoochee Valley by providing a customized leadership development workshop, while analysts also highlighted that its second-quarter results were expected to benefit from growth in net earned premiums in the U.S. segment driven by higher sales. Beyond underscoring anticipated strength in its U.S. premium base, Aflac’s outreach shows how its internal leadership capabilities are being applied to strengthen community organizations. Next, we’ll...

Preformed Line Products (PLPC) has just completed a multi year share repurchase program and released fresh quarterly results, giving investors new information on capital returns and recent operating performance to factor into their view of the stock. See our latest analysis for Preformed Line Products. That completed buyback and the stronger recent earnings sit beside a sharp shift in market sentiment, with Preformed Line Products showing a 30 day share price return of 41.2% and a year to...

U-Haul Holding stock barely flinched, up about 1.4% on the day, even as the headline told a more complicated story. Q1 FY2027 brought solid revenue of US$1.68b and a return to profit, with basic earnings per share of US$0.63 after recent quarterly losses. Yet net income of US$122.9m sat below last year’s US$142.3m, and investors had to weigh that softer profit against evidence that the core moving and storage engine is still pulling in more dollars. The market reaction looked calm; the...

Blue Bird just delivered one of the sharpest disconnects of this earnings season. The stock dropped 14.2% to about US$66 after the Q3 report, even though the company reported US$517.2m in revenue and basic earnings per share of US$5.41. That is a large increase from earlier in the fiscal year and leaves the trailing P/E near 7.4x compared with a much higher machinery industry average. Coming into the report, Blue Bird shares had already been under pressure over the last month. This quarter...

Why IDACORP earnings and guidance matter for investors IDACORP (IDA) drew fresh attention after reporting second quarter 2026 results that showed higher sales, revenue, net income and earnings per share compared with a year earlier, along with slightly raised full year earnings guidance. See our latest analysis for IDACORP. Over the past year, IDACORP has paired its raised 2026 earnings guidance with a 15.66% total shareholder return, while the share price is up 10.69% year to date despite a...

In early August 2026, Addus HomeCare reported higher net income of US$27.61 million and diluted EPS of US$1.49 for the second quarter, alongside six‑month earnings growth versus the prior year, and outlined plans to pursue larger acquisitions supported by reduced bank debt of US$64.3 million. A distinctive takeaway is management’s focus on expanding personal care and selectively adding home health assets, using its strengthened balance sheet to deepen geographic coverage and relationships...

Why Core Natural Resources Stock Is Back on Investors’ Radar Core Natural Resources (CNR) drew fresh attention today after reporting second quarter 2026 results that showed higher sales, a move back to net income, a quarterly dividend, and progress on its ongoing share repurchase program. See our latest analysis for Core Natural Resources. The strong second quarter update, dividend declaration, and confirmation of 2026 sales guidance have coincided with a sharp shift in sentiment toward Core...

Howard Hughes Holdings stock jumped about 3.6% to around US$68 after the Q2 print, even though the shares are still down roughly 7.9% over the past month. The market is reacting to a headline quarter that combined a sharp revenue increase to about US$1.1b with a clear message. The real story was not a single-quarter beat or miss. It was management emphasizing a long-horizon plan that uses its real estate cash flows and a growing insurance platform to reshape how investors should think about...

Standard BioTools stock inched up about 3% to roughly US$0.80 after earnings, a small bounce that sits awkwardly against a longer slide of more than 20% over the past three months. The headline is not growth. It is the size and persistence of the losses. Q2 revenue came in around US$20.1m while the company reported a net loss from continuing operations over the past year of roughly US$53.9m. For anyone thinking beyond today’s tick higher, the key debate is whether that loss profile can...

Corpay stock barely flinched after earnings, up less than 1% to about $398, even as the company posted one of its cleanest quarters in recent memory. The market mood looks cautious while the numbers tell a stronger story. The headline is simple. Revenue reached about $1.34b and cash earnings per share hit a record $7 in the quarter. Management lifted full year cash EPS and revenue guidance. With the stock already up double digits over the past month, today’s muted move hints more at investors...

Natera (NTRA) is back in focus after reporting Q2 2026 earnings on August 6, with revenue of US$752.75 million and a narrower net loss, alongside fresh regulatory progress for Signatera in Japan. See our latest analysis for Natera. Natera’s share price has eased in the short term, with a 1-month share price return of down 5.65% and a 7-day share price return of down 1.59%. Momentum over longer periods remains strong, reflected in a 90-day share price return of 36.62% and a 1-year total...

Duolingo just handed investors a sentiment test. The stock dropped about 9% today to US$122.58, even though the quarter featured solid revenue of US$298.454m and positive basic earnings per share of US$0.71. The market is reacting as if the growth story has cracked. The financials point to something more nuanced. Coming into this print, Duolingo had already cooled off in the short term, with shares down over the past week and month, while still positive over the past quarter. Today’s move is...

Arcutis Biotherapeutics slipped about 2.5% today to US$26.43, even though the company just turned in what many biotech investors look for most. The dermatology specialist posted Q2 net product revenue of US$129.9m and reported US$15m of net income. That short term pullback sits against a bigger picture of rising revenue guidance for 2026 and a stock that had gained roughly 25% over the past three months. The rest of this earnings breakdown focuses on how durable that profit turn and growth...

RxSight walked into this quarter with a stock that had been roughly flat over the past week and modestly higher over the past month. The immediate reaction told a different story. The share price slipped about 3% to US$6.08 after the Q2 release, as investors focused on pressure in the income statement rather than the long runway often associated with its light adjustable lens technology. The headline from these earnings is margin and loss pressure. Revenue for Q2 came in at US$33.7m while the...

Talen Energy stock came into this earnings day under pressure after a weak three month stretch, then jumped 2.6% to US$338.31 as investors absorbed a very different story from the income statement. The headline is simple: power generation and cash generation stole the show while reported earnings swung back into loss territory. Quarterly revenue landed at US$747 million and Talen Energy reported a net loss of US$92 million, yet the company highlighted strong adjusted earnings before interest,...

Energy Recovery stock barely flinched after earnings, slipping about 1.5%, yet the numbers tell a louder story than the price tape suggests. The headline is a sharp earnings reset. Q2 delivered a revenue haul of about US$12 million, while the company reported a loss of roughly US$3.2 million, a clear squeeze compared with its profit rich recent history. For a stock that had been treading water over the past month, the market now appears to be wrestling with one thing above all else:...

Tyler Technologies, Inc. recently announced that the Tennessee Comptroller of the Treasury has gone live with the company’s largest cloud deployment of its Enterprise Assessment & Tax solution, a statewide implementation supporting nearly 800 users and 86 counties following a multi-year migration to an Amazon Web Services-based platform completed in May 2026. This project highlights how long-term public sector clients are scaling Tyler’s cloud-hosted and native solutions to modernize complex...

Traeger walked into this earnings print with the stock up over the past three months, yet the shares were hit hard today with a one-day drop of almost 13%. That indicates expectations had quietly crept higher. The headline from the quarter is not the top line. Revenue landed at about US$120 million, but the real story is a small adjusted profit on the income line alongside a reported net loss and an updated full-year revenue guide that now points lower. The market is voting on that tension in...

In early August 2026, Globus Medical reported second-quarter 2026 results showing sales of US$789.61 million, up from US$745.34 million a year earlier, while net income decreased to US$151.57 million from US$202.85 million and diluted EPS from continuing operations eased to US$1.10 from US$1.49. For the first half of 2026, sales grew to US$1.55 billion from US$1.34 billion, yet net income and diluted EPS from continuing operations were roughly flat versus the prior year, highlighting that...

Akebia Therapeutics just took a 26% hit, with the stock sliding to about US$0.95, as investors reacted to a quarter that put its valuation strain back in the spotlight. The immediate trigger was Q2 revenue of US$49.1 million and another quarterly net loss. The key issue is what that means for a stock that trades on a very low price to sales ratio and a large gap to modelled future cash flow value. The short term looks painful on the screen. The bigger question is how long Akebia can run its...

Southwest Gas Holdings stock barely flinched after earnings, edging up about 2% to US$92.40, even though the headline story is about pressure on profitability rather than a blowout quarter. The shares had been trading at a rich 23.5x trailing P/E with strong trailing earnings momentum going into this report, so any hint of strain matters. The key issue this time is the squeeze between earnings power and the balance sheet. Management reaffirmed guidance and highlighted roughly US$1.25b of...

Herbalife shareholders woke up to a harsh verdict. The stock dropped about 9% to US$11.51 on the first trading day after earnings, even though the company delivered its fourth straight quarter of year on year sales growth and reported Q2 net sales of about US$1.3b. The real shock came on the bottom line. Herbalife swung from a profitable Q1 to a Q2 loss of US$26.3m as a refinancing related debt extinguishment charge hit earnings, even while adjusted EBITDA landed near the high end of...

Sterling Infrastructure, Inc. recently reported past second-quarter 2026 results showing sales of US$1.17 billion and net income of US$155.83 million, both higher than a year earlier, and raised its full-year 2026 guidance to revenue of US$4.00 billion–US$4.15 billion and diluted EPS of US$17.25–US$17.85. Management also signaled that capacity, not demand, is now the main constraint, as the company pursues further acquisitions to broaden services and add project execution bandwidth. We’ll...